In our newly released Partnership Report, we highlight how the Global Fund and Unitaid collaborate to accelerate equitable access to lifesaving health products that prevent, detect and treat HIV, TB and malaria. By combining Unitaid’s investments in innovative new health products with the Global Fund’s proven ability to take those tools to scale around the world, we increase return on investment, save more lives and reach the health-related Sustainable Development Goals more quickly.
The Global Fund and Unitaid each play a distinct and complementary role in advancing access to new products and approaches to save lives. Unitaid connects a broad range of partners to identify and create innovative new health products, and then brings them to market quickly and affordably for the people that need them most. The Global Fund, as one of the largest providers of key health commodities, supports over 120 countries in deploying these innovations at scale and at affordable prices.
New products and novel approaches to fight HIV, TB and malaria can transform care, averting countless cases of illness and death. But lifesaving medicines and tools will have limited impact without a concerted effort to ensure access for all who need them. Our collaboration spans all three diseases and has included ensuring equitable access to next-generation mosquito nets to stop malaria-carrying mosquitoes, game-changing treatments for HIV, and more effective TB preventive therapy.
A joint analysis by Unitaid and the Global Fund estimated the return on investment and the impact these health innovations will have on the death toll from the three diseases between 2024-2026. That review showed that health innovations maximize the impact of investments into the Global Fund and broader HIV, TB, and malaria efforts, accelerating the overall response and delivering the same reduction in deaths more than three years faster. The health and economic gains from every dollar invested in the three diseases are 16% higher with health innovations like those piloted by Unitaid and scaled up by the Global Fund.
Source: Unitaid